Cargando…
Targeting endosialin/CD248 through antibody-mediated internalization results in impaired pericyte maturation and dysfunctional tumor microvasculature
Over-expression of endosialin/CD248 (herein referred to as CD248) has been associated with increased tumor microvasculature in various tissue origins which makes it an attractive anti-angiogenic target. In an effort to target CD248, we have generated a human CD248 knock-in mouse line and MORAb-004,...
Autores principales: | Rybinski, Katherine, Imtiyaz, Hongxia Z., Mittica, Barrie, Drozdowski, Brian, Fulmer, James, Furuuchi, Keiji, Fernando, Shawn, Henry, Marianne, Chao, Qimin, Kline, Brad, Albone, Earl, Wustner, Jason, Lin, JianMin, Nicolaides, Nicholas C., Grasso, Luigi, Zhou, Yuhong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4694842/ https://www.ncbi.nlm.nih.gov/pubmed/26327620 |
Ejemplares similares
-
Novel antibody probes for the characterization of endosialin/TEM-1
por: O'shannessy, Daniel J., et al.
Publicado: (2016) -
Antibody‐drug conjugate MORAb‐202 exhibits long‐lasting antitumor efficacy in TNBC PDx models
por: Furuuchi, Keiji, et al.
Publicado: (2021) -
A Differential Role for CD248 (Endosialin) in PDGF-Mediated Skeletal Muscle Angiogenesis
por: Naylor, Amy J., et al.
Publicado: (2014) -
Generation and characterization of high affinity human monoclonal antibodies that neutralize staphylococcal enterotoxin B
por: Drozdowski, Brian, et al.
Publicado: (2010) -
Endosialin/CD248 may be a potential therapeutic target to prevent the invasion and metastasis in osteosarcoma
por: Kondo, Yumiko, et al.
Publicado: (2022)